Search Results - "Molica, Francesco"
-
1
Effectiveness and safety of secukinumab in ankylosing spondylitis and psoriatic arthritis: a 52-week real-life study in an Italian cohort
Published in Advances in rheumatology (London, England) (27-03-2023)“…Secukinumab has shown high efficacy in randomized controlled trials in both ankylosing spondylitis (AS) and psoriatic arthritis (PsA). Here, we investigated…”
Get full text
Journal Article -
2
Influence of Safety Warnings on the Prescribing Attitude of JAK Inhibitors for Rheumatoid Arthritis in Italy
Published in Journal of clinical medicine (04-07-2024)“…The Janus kinase inhibitors (JAKi) tofacitinib (TOFA), baricitinib (BARI), upadacitinib (UPA), and filgotinib (FILGO) are effective drugs for the treatment of…”
Get full text
Journal Article -
3
Therapeutic Effects of Apremilast on Enthesitis and Dactylitis in Real Clinical Setting: An Italian Multicenter Study
Published in Journal of clinical medicine (07-06-2023)“…Enthesitis and dactylitis are difficult-to-treat features of psoriatic arthritis (PsA), leading to disability and affecting quality of life. The aim of this…”
Get full text
Journal Article -
4
Reassessing Cohesion Policy Through the Lens of the New EU Industrial Policy
Published in Journal of common market studies (14-05-2024)“…Abstract The research note explores the role of cohesion policy in the emerging EU industrial agenda with the view to anchor it in the new industrial policy…”
Get full text
Journal Article -
5
Regional innovation policies and directionality: exploring the role of conditionality
Published in European planning studies (02-08-2024)“…The paper investigates the use of conditionality to achieve directionality within transformative innovation policies. To date, research in this area has been…”
Get full text
Journal Article -
6
Predictors of DAPSA Response in Psoriatic Arthritis Patients Treated with Apremilast in a Retrospective Observational Multi-Centric Study
Published in Biomedicines (01-02-2023)“…To date, only a few real-world-setting studies evaluated apremilast effectiveness in psoriatic arthritis (PsA). The aims of this retrospective observational…”
Get full text
Journal Article -
7
Financial Absorption of Cohesion Policy Funds: How Do Programmes and Territorial Characteristics Influence the Pace of Spending?
Published in Journal of common market studies (30-06-2024)“…Abstract Using data from the execution of 2014–2020 cohesion policy, this article presents a novel indicator to measure how fast European territories were able…”
Get full text
Journal Article -
8
Missions and Cohesion Policy: is there a match?
Published in Science & public policy (31-05-2024)“…Abstract This paper explores possibilities for cross-fertilization between the mission-oriented approach (MOA), informing the European Union (EU) Missions, and…”
Get full text
Journal Article -
9
Measuring achievements: Can cohesion policy programmes effectively monitor their performance?
Published in Investigaciones regionales (09-10-2024)“…The paper investigates the ability of Cohesion Policy programmes to define accurate policy outputs and to reliably monitor their own performance through…”
Get full text
Journal Article -
10
'Co-Funded by the EU'vs 'From the American people': Refreshing the communication on EU Cohesion Policy
Published in Investigaciones regionales (01-01-2019)“…The authors review the communication agenda on the EU Cohesion Policy. In recent years this issue has attracted unprecedented attention, in particular in the…”
Get full text
Journal Article -
11
Co-funded by the EU’ vs ‘From the American people’: refreshing the communication on EU cohesion policy
Published in Investigaciones regionales (01-01-2019)“…The authors review the communication agenda on the EU Cohesion Policy. In recent years this issue has attracted unprecedented attention, in particular in the…”
Get full text
Journal Article -
12
Apremilast retention rate in clinical practice: observations from an Italian multi-center study
Published in Clinical rheumatology (01-10-2022)“…Objective There are few real-world setting studies focused on apremilast effectiveness (i.e., retention rate) in psoriatic arthritis (PsA). The main aim of…”
Get full text
Journal Article -
13
Analysis of survival rate and persistence predictors of baricitinib in real-world data from a large cohort of rheumatoid arthritis patients
Published in Current research in pharmacology and drug discovery (01-01-2024)“…The persistence in therapy of rheumatoid arthritis drugs and particularly bDMARD is a limiting factor for their long-term use. The randomized controlled trials…”
Get full text
Journal Article -
14
Multicenter observational study on the efficacy of selective Janus Kinase-1 inhibitor upatacitinib in rheumatoid arthritis
Published in Minerva medica (01-08-2024)“…Upadacitinib (UPA) is a selective, reversible Janus kinase inhibitor (JAKi) approved for the treatment of RA. However, there is still no solid evidence on the…”
Get more information
Journal Article